Public trust on regulatory decisions: The European Medicines Agency and the AstraZeneca COVID-19 vaccine label.

Vaccine

Université de Paris, Faculté de Medicine, Inserm, CIC 1417, F-CRIN, Innovative Clinical Research Network in Vaccinology (I-REIVAC), and Assistance Publique-Hôpitaux de Paris, CIC Cochin Pasteur, Hôpital Cochin Paris, Paris, France.

Published: July 2021

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190873PMC
http://dx.doi.org/10.1016/j.vaccine.2021.05.095DOI Listing

Publication Analysis

Top Keywords

public trust
4
trust regulatory
4
regulatory decisions
4
decisions european
4
european medicines
4
medicines agency
4
agency astrazeneca
4
astrazeneca covid-19
4
covid-19 vaccine
4
vaccine label
4

Similar Publications

BackgroundClimate change is a huge public health threat, necessitating reductions in carbon emissions, particularly from single-use plastics like non-sterile gloves (NSG). This quality improvement project aims to explore whether use of targeted educational material changes staff attitudes towards NSG use in clinical practice within a Sexual Health and HIV department.MethodsA pre-intervention survey was circulated to all clinicians.

View Article and Find Full Text PDF

Mental health disorders contribute to a lack of HIV care retention and adherence. Pharmacotherapy for mental health treatment may increase retention and adherence. However, there is often a lack of pharmacotherapy services for mental health treatment available in HIV care.

View Article and Find Full Text PDF

Background: Many patients with ulcerative colitis report ongoing diarrhoea even when their disease is stable and in remission.

Design: MODULATE was a pragmatic, multicentre, seamless, adaptive, phase 2/3 open-label, parallel-group, multiarm multistage randomised controlled trial.

Setting And Participants: People aged over 18 years with stable ulcerative colitis who had diarrhoea, recruited from secondary care sites in the United Kingdom.

View Article and Find Full Text PDF

Purpose Of Review: This study aims to examine the ethical and legal discourse surrounding normothermic regional perfusion (NRP) for donation after circulatory death (DCD).

Recent Findings: NRP is well established within Europe but faces challenges in the US and is not utilized in a variety of other countries. NRP compliance with the dead donor rule (DDR) and Uniform Declaration of Death Act (UDDA) is the most significant recently addressed US ethical and legal issue.

View Article and Find Full Text PDF

In this concept paper, we introduce epilepsy-heart syndrome as a shared burden of illness between epilepsy and cardiac disorders. This pragmatic definition is agnostic of which condition came first (the epilepsy or the cardiac disorder), recognising that these conditions can each serve as a risk factor for the other owing to a bidirectional relationship that exists between the brain and the heart. To provide clinical context, we include ictal asystole as an example phenotype of epilepsy-heart syndrome.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!